Study Spotlight

Study Spotlight

Acetyl-L-carnitine May Improve Health Quality of Life for Patients with Hepatitis C


In this study, researchers found that supplementation with acetyl-L-carnitine may offer marked benefits to chronic hepatitis B patients. Sixty patients with chronic hepatitis C underwent treatment with pegylated-interferon-a 2b (Peg-IFN-a 2b) + ribavirin (RBV) (group A; n=29) or Peg-IFN-a 2b + RBV + ALC (group B; n=31) for 12 months. At the end of the study, patients treated with ALC supplementation in conjunction with standard treatment benefited from lowered levels of liver damage and a higher sustained virological response. They also benefitted from greater mental and physical well-being and enjoyed an improved health related quality of life, which in turn might prompt better adherence to treatment regime. These results suggest that supplementation with acetyl-L-carnitine may be of significant benefit in decreasing fatigue and improving quality of life in persons with hepatitis C.

 Click Here to visit the journal website. Subscription required to view the full text of the article.

Socialize
Website by Webfitters